What is the Fiscal Year for Adicet Bio?
Date: November 13, 2026
Adicet Bio's current fiscal year starts on December 27, 2025, and ends on December 26, 2026. Their current quarter is Q4, which ends on December 26, 2026.
Current Fiscal Year Overview
Fiscal Year Start
December 27, 2025
Fiscal Year End
December 26, 2026
Current Quarter
Q4
Current Quarter End
December 26, 2026
Quarterly Breakdown
Q1
Dec 27, 2025 – Mar 26, 2026
Q2
Mar 27, 2026 – Jun 26, 2026
Q3
Jun 27, 2026 – Sep 26, 2026
Q4
Sep 27, 2026 – Dec 26, 2026
Company Information
Headquarters
Redwood City, California
Industry
Biotechnology Research
Stock Symbol
ACET
Website
https://adicetbio.comDescription
Adicet Bio, Inc. (Nasdaq: ACET) is a clinical-stage biotechnology company discovering and developing a broad pipeline of allogeneic gamma delta T cell therapies, engineered with chimeric antigen receptors (CARs), alongside differentiated in vivo CAR-T therapies with the potential to redefine treatment across autoimmune diseases, hematologic malignancies and solid tumors. For more information, please visit our website at https://www.adicetbio.com. Your safety as a job seeker matters to us. Please be cautious of fraudulent recruitment activity claiming to represent Adicet. All approved positions are accessible via the Adicet Careers page at https://www.adicetbio.com/careers/openings/
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Adicet Bio and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.